Huai-Xiang Hao - Novartis Institute for Biological Research

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 65 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table 4 from Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus

Hung Huynh,Huai-Xiang Hao, Stephen L. Chan, David Chen,Richard Ong,Khee Chee Soo,Panisa Pochanard,David Yang,David Ruddy,Manway Liu,Adnan Derti,Marissa N. Balak,Michael R. Palmer, Yan Wang, Benjamin H. Lee,Dalila Sellami,Andrew X. Zhu,Robert Schlegel,Alan Huang

crossref（2023）

引用0浏览0引用

Supplementary Figure Legends, Tables 1 - 3 from Loss of Tuberous Sclerosis Complex 2 (TSC2) is Frequent in Hepatocellular Carcinoma and Predicts Response to Mtorc1 Inhibitor Everolimus

Hung Huynh,Huai-Xiang Hao,Stephen L. Chan, David Chen,Richard Ong,Khee Chee Soo,Panisa Pochanard,David Yang,David Ruddy,Manway Liu,Adnan Derti,Marissa N. Balak,Michael R. Palmer,Yan Wang, Benjamin H. Lee,Dalila Sellami,Andrew X. Zhu,Robert Schlegel,Alan Huang

openalex（2023）

引用0浏览0引用

Supplementary Figure Legend from Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

crossref（2023）

引用0浏览0引用

Supplementary Figure 3 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Hengyu Lu, Chen Liu,Roberto Velazquez, Hongyun Wang, Lukas Manuel Dunkl,Malika Kazic-Legueux,Anne Haberkorn,Eric Billy,Eusebio Manchado,Saskia M. Brachmann, Susan E. Moody, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Morvarid Mohseni,Huai-Xiang Hao

openalex（2023）

引用0浏览0引用

Supplementary Table 1 from Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

crossref（2023）

引用0浏览0引用

Supplementary Table 3 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Hengyu Lu,Chen Liu,Roberto Velazquez,Hongyun Wang, Lukas Manuel Dunkl,Malika Kazic-Legueux,Anne Haberkorn,Eric Billy,Eusebio Manchado,Saskia M. Brachmann,Susan E. Moody, Jeffrey A. Engelman,Peter S. Hammerman,Giordano Caponigro, Morvarid Mohseni,Huai-Xiang Hao

crossref（2023）

引用0浏览0引用

Supplementary Figure 1 from Loss of Tuberous Sclerosis Complex 2 (TSC2) is Frequent in Hepatocellular Carcinoma and Predicts Response to Mtorc1 Inhibitor Everolimus

Hung Huynh,Huai-Xiang Hao,Stephen L. Chan, David Chen,Richard Ong,Khee Chee Soo,Panisa Pochanard,David Yang,David A. Ruddy,Manway Liu,Adnan Derti,Marissa N. Balak,Michael R. Palmer,Yan Wang, Benjamin H. Lee,Dalila Sellami,Andrew X. Zhu,Robert Schlegel,Alan Huang

openalex（2023）

引用0浏览0引用

Supplementary Figure 3 from Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

Chen Liu,Hengyu Lu,Hongyun Wang, Alice Loo,Xiamei Zhang,Guizhi Yang,Colleen Kowal,Scott Delach,Ye Wang,Silvia Goldoni,William D. Hastings,Karrie Wong,Hui Gao,Matthew J. Meyer,Susan E. Moody,Matthew J. LaMarche, Jeffrey A. Engelman,Juliet A. Williams,Peter S. Hammerman,Tinya J. Abrams, Morvarid Mohseni,Giordano Caponigro,Huai-Xiang Hao

openalex（2023）

引用0浏览0引用

Figure S2 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

openalex（2023）

引用0浏览0引用

Supplementary Figure 2 from Loss of Tuberous Sclerosis Complex 2 (TSC2) is Frequent in Hepatocellular Carcinoma and Predicts Response to Mtorc1 Inhibitor Everolimus

openalex

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn